Insider · CIK 0001706426

Terrillion Scott

Reports to the SEC for 1 company · STAMFORD, CT

sec.gov

Transactions

Companies

Filings

CIK

0001706426

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-28	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−163 sh	$4.76	−$775.88	7,190
2024-04-05	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−2,753 sh	$0.83	−$2,284.99	88,247
2024-02-29	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−3,293 sh	$0.89	−$2,930.77	91,000
2024-02-01	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+13.5K sh	—	—	102,063
2023-06-23	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−2,483 sh	$3.51	−$8,715.33	88,563
2023-04-04	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−2,481 sh	$4.91	−$12.2K	91,046
2023-03-03	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−6,256 sh	$9.71	−$60.7K	93,527
2023-03-01	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+81K sh	—	—	81,000
2023-02-08	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−7,770 sh	$0.53	−$4,118.1	94,293
2022-12-21	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−2,561 sh	$11.27	−$28.9K	99,783
2022-04-01	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−1,642 sh	$11.91	−$19.6K	102,344
2022-03-03	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−1,787 sh	$11.38	−$20.3K	103,986
2022-02-28	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+5,333 sh	—	—	105,773
2022-02-25	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+20K sh	—	—	102,412
2022-02-25	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−1,972 sh	$10.29	−$20.3K	100,440
2022-02-25	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+40K sh	—	—	40,000
2021-12-17	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+11.5K sh	—	—	82,412
2021-08-30	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−1,759 sh	$14.20	−$25K	70,917
2021-08-24	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+5,334 sh	—	—	72,676
2021-03-30	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+16K sh	—	—	67,342
2021-03-30	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+32K sh	—	—	32,000
2021-03-05	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−3,090 sh	$17.98	−$55.6K	51,342
2021-03-04	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+10K sh	—	—	54,432
2021-02-25	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−4,004 sh	$19.33	−$77.4K	44,432
2021-02-23	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+6,000 sh	—	—	48,436
2020-12-30	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−1,946 sh	$15.30	−$29.8K	42,436
2020-12-23	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+6,000 sh	—	—	44,382
2020-04-21	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−2,721 sh	$15.56	−$42.3K	38,382
2020-04-17	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+8,334 sh	—	—	41,103
2020-02-24	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+16K sh	—	—	32,769
2020-02-24	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+32K sh	—	—	32,000
2019-12-04	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−3,980 sh	$17.05	−$67.9K	16,769
2019-12-02	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+8,333 sh	—	—	20,749
2019-05-29	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−2,303 sh	$21.38	−$49.2K	12,416
2019-05-28	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+8,333 sh	—	—	14,719
2019-03-06	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+75K sh	—	—	75,000
2018-12-28	TVRDTvardi Therapeutics, Inc.S Sale	SEC'Y; CHIEF COMPLIANCE & G.C.	SSale	−3,100 sh	$12.51	−$38.8K	6,386
2018-12-27	TVRDTvardi Therapeutics, Inc.A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+9,486 sh	—	—	9,486
2018-03-09	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	SEC'Y; CHIEF COMPLIANCE & G.C.	AAward	+46.5K sh	—	—	46,500

Recent filings

Accepted (ET)
Mar 44
Terrillion Scott0001415889-25-006575
SEC(opens sec.gov)
Apr 94
Terrillion Scott0001415889-24-010569
SEC(opens sec.gov)
Mar 44
Terrillion Scott0001415889-24-006282
SEC(opens sec.gov)
Feb 124
Terrillion Scott0001415889-24-003408
SEC(opens sec.gov)
Feb 54
Terrillion Scott0001415889-24-002536
SEC(opens sec.gov)
Jun 274
Terrillion Scott0001209191-23-039884
SEC(opens sec.gov)
Apr 64
Terrillion Scott0001209191-23-023607
SEC(opens sec.gov)
Mar 74
Terrillion Scott0001209191-23-016790
SEC(opens sec.gov)
Mar 34
Terrillion Scott0001209191-23-015577
SEC(opens sec.gov)
Dec 234
Terrillion Scott0001209191-22-062628
SEC(opens sec.gov)
Apr 54
Terrillion Scott0001209191-22-023249
SEC(opens sec.gov)
Mar 44
Terrillion Scott0001209191-22-016431
SEC(opens sec.gov)
Mar 14
Terrillion Scott0001209191-22-013994
SEC(opens sec.gov)
Dec 214
Terrillion Scott0001209191-21-070805
SEC(opens sec.gov)
Sep 14
Terrillion Scott0001209191-21-054304
SEC(opens sec.gov)
Aug 264
Terrillion Scott0001209191-21-053537
SEC(opens sec.gov)
Apr 14
Terrillion Scott0001209191-21-024299
SEC(opens sec.gov)

Companies

Tvardi Therapeutics, Inc.SEC'Y; CHIEF COMPLIANCE & G.C.TVRD

Address

C/O CARA THERAPEUTICS, INC. 400 ATLANTIC STREET, SUITE 500

STAMFORD, CT, 06901